tiprankstipranks
Advertisement
Advertisement
Ardelyx price target raised to $18 from $10 at H.C. Wainwright
PremiumThe FlyArdelyx price target raised to $18 from $10 at H.C. Wainwright
2M ago
Ardelyx: Strong Ibsrela Momentum, De-Risked CIC Upside, and Patent-Backed Undervaluation Support Buy Rating
Premium
Ratings
Ardelyx: Strong Ibsrela Momentum, De-Risked CIC Upside, and Patent-Backed Undervaluation Support Buy Rating
2M ago
Ardelyx reports Q4 EPS 0c, consensus 1c
Premium
The Fly
Ardelyx reports Q4 EPS 0c, consensus 1c
2M ago
Ardelyx price target raised to $13 from $10 at TD Cowen
PremiumThe FlyArdelyx price target raised to $13 from $10 at TD Cowen
2M ago
Ardelyx: Commercial Momentum, Expanded Ibsrela Opportunity, and Strengthened IP Underpin Buy Rating
Premium
Ratings
Ardelyx: Commercial Momentum, Expanded Ibsrela Opportunity, and Strengthened IP Underpin Buy Rating
2M ago
Ardelyx announces first patient dosed in ACCEL
Premium
The Fly
Ardelyx announces first patient dosed in ACCEL
2M ago
Ardelyx: Strengthening Commercial Trajectory, Expanded IP Protection to 2041, and Pipeline Upside Support Raised $17 Buy Target
PremiumRatingsArdelyx: Strengthening Commercial Trajectory, Expanded IP Protection to 2041, and Pipeline Upside Support Raised $17 Buy Target
3M ago
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
3M ago
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100